Ken Griffin Orasure Technologies Inc Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$4.2 - $6.18 $36,960 - $54,384	8,800 Added 463.16%	10,700 $45,000
Q1 2024 May 15, 2024	SELL	$6.08 - $8.28 $54,112 - $73,692	-8,900 Reduced 82.41%	1,900 $11,000
Q4 2023 Feb 14, 2024	BUY	$5.13 - $8.35 $33,858 - $55,110	6,600 Added 157.14%	10,800 $88,000
Q3 2023 Nov 14, 2023	BUY	$4.4 - $6.91 $14,080 - $22,112	3,200 Added 320.0%	4,200 $24,000
Q2 2023 Aug 14, 2023	BUY	$4.88 - $7.39 $4,392 - $6,651	900 Added 900.0%	1,000 $5,000
Q1 2023 May 15, 2023	SELL	$4.66 - $6.52 $85,744 - $119,967	-18,400 Reduced 99.46%	100 $0
Q4 2022 Feb 14, 2023	BUY	$3.7 - $5.29 $1,110 - $1,587	300 Added 1.65%	18,500 $89,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $4.61 $93,840 - $159,045	-34,500 Reduced 65.46%	18,200 $69,000

220

67.2M

8.5K

11.8K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $308M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.